Things are not so agile in the Biotech space...don't know why ANP doesn't apply to TGA in OZ for accelerated program...even at 25mg dose.
Meanwhile, traditional steroids dominate the inflammation market that's worth over $100B per year.
Will Big Pharma even allow ANP to get to market in the US outside of DMD?
Not sure which companies own the corticosteroids products BUT you can bet they'll be protecting their turf.
Ann: Trading Halt, page-15
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
